Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / adma biologics fy22 numbers key inflection point

ADMA - ADMA Biologics: FY22 Numbers Key Inflection Point

ADMA Biologics Inc

Summary

  • ADMA Biologics continues to outperform benchmarks, after offering investors a source of tactical alpha across the past 18 months.
  • The market continues to reward its hypothesis in treating primary humoral immunodeficiency.
  • Shares have extended the rally in 2023 and further upside would see the ADMA share price push above its previous highs.
  • The company's FY22 results, to be released in March, are a key inflection point to see what's in store for investors this year.
  • Net-net, we rate ADMA a buy.

For further details see:

ADMA Biologics: FY22 Numbers Key Inflection Point
Stock Information
Company Name: ADMA Biologics Inc
Stock Symbol: ADMA
Market: NASDAQ
Website: admabiologics.com
Menu
ADMA ADMA Quote ADMA Short ADMA News ADMA Articles ADMA Message Board
Get ADMA Alerts

News, Short Squeeze, Breakout and More Instantly...